{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T07:48:52Z","timestamp":1720424932255},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12253-018-0408-6","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T20:12:01Z","timestamp":1523045521000},"page":"979-986","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores"],"prefix":"10.1007","volume":"25","author":[{"given":"Sami-Ramzi","family":"Leyh-Bannurah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Latour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Zaffuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andree-Anne","family":"Grosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bud\u00e4us","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armen G.","family":"Aprikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil E.","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin E.","family":"Gleave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"issue":"2","key":"408_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.eururo.2015.05.041","volume":"69","author":"M Santoni","year":"2016","unstructured":"Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, Epstein JI, Cascinu S, Briganti A, Catto JW, Montorsi F, Montironi R (2016) Current Histopathologic and molecular Characterisations of prostate Cancer: towards individualised prognosis and therapies. European Urology 69(2):186\u2013190. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.05.041","journal-title":"European Urology"},{"issue":"4","key":"408_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12253-010-9270-x","volume":"16","author":"D Wittschieber","year":"2010","unstructured":"Wittschieber D, Kollermann J, Schlomm T, Sauter G, Erbersdobler A (2010) Nuclear grading versus Gleason grading in small samples containing prostate cancer: a tissue microarray study. Pathology oncology research: POR 16(4):479\u2013484. \n                    https:\/\/doi.org\/10.1007\/s12253-010-9270-x","journal-title":"Pathology oncology research: POR"},{"issue":"3","key":"408_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA (2016) A contemporary prostate Cancer grading system: a validated alternative to the Gleason score. European Urology 69(3):428\u2013435. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.06.046","journal-title":"European Urology"},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.eururo.2015.11.036","volume":"69","author":"S Loeb","year":"2015","unstructured":"Loeb S, Folkvaljon Y, Robinson D, Lissbrant IF, Egevad L, Stattin P (2015) Evaluation of the 2015 Gleason grade groups in a Nationwide population-based cohort. European Urology 69:1135\u20131141. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.11.036","journal-title":"European Urology"},{"issue":"4","key":"408_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","volume":"69","author":"G Sauter","year":"2016","unstructured":"Sauter G, Steurer S, Clauditz TS, Krech T, Wittmer C, Lutz F, Lennartz M, Janssen T, Hakimi N, Simon R, von Petersdorff-Campen M, Jacobsen F, von Loga K, Wilczak W, Minner S, Tsourlakis MC, Chirico V, Haese A, Heinzer H, Beyer B, Graefen M, Michl U, Salomon G, Steuber T, Budaus LH, Hekeler E, Malsy-Mink J, Kutzera S, Fraune C, Gobel C, Huland H, Schlomm T (2016) Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens. European Urology 69(4):592\u2013598. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.10.029","journal-title":"European Urology"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00345-016-1897-0","volume":"35","author":"N Timilshina","year":"2016","unstructured":"Timilshina N, Ouellet V, Alibhai SM, Mes-Masson AM, Delvoye N, Drachenberg D, Finelli A, Jammal MP, Karakiewicz P, Lapointe H, Lattouf JB, Lynch K, Paradis JB, Sitarik P, So A, Saad F (2016) Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study. World Journal of Urology 35:595\u2013603. \n                    https:\/\/doi.org\/10.1007\/s00345-016-1897-0","journal-title":"World Journal of Urology"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00345-016-1861-z","volume":"35","author":"CP Meyer","year":"2016","unstructured":"Meyer CP, Hansen J, Boehm K, Tilki D, Abdollah F, Trinh QD, Fisch M, Sauter G, Graefen M, Huland H, Chun FK, Ahyai SA (2016) Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins. World Journal of Urology 35:199\u2013206. \n                    https:\/\/doi.org\/10.1007\/s00345-016-1861-z","journal-title":"World Journal of Urology"},{"issue":"4","key":"408_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.juro.2010.06.018","volume":"184","author":"L Budaus","year":"2010","unstructured":"Budaus L, Isbarn H, Eichelberg C, Lughezzani G, Sun M, Perrotte P, Chun FK, Salomon G, Steuber T, Kollermann J, Sauter G, Ahyai SA, Zacharias M, Fisch M, Schlomm T, Haese A, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI (2010) Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage. The Journal of Urology 184(4):1341\u20131346. \n                    https:\/\/doi.org\/10.1016\/j.juro.2010.06.018","journal-title":"The Journal of Urology"},{"issue":"2","key":"408_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.eururo.2008.08.015","volume":"55","author":"H Isbarn","year":"2009","unstructured":"Isbarn H, Ahyai SA, Chun FK, Budaus L, Schlomm T, Salomon G, Zacharias M, Erbersdobler A, Kollermann J, Sauter G, Huland H, Graefen M, Steuber T (2009) Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series. European Urology 55(2):394\u2013401. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2008.08.015","journal-title":"European Urology"},{"issue":"6","key":"408_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/cncr.23293","volume":"112","author":"N Suardi","year":"2008","unstructured":"Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, Klein EA, Karakiewicz PI (2008) A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer 112(6):1254\u20131263. \n                    https:\/\/doi.org\/10.1002\/cncr.23293","journal-title":"Cancer"},{"issue":"3","key":"408_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.eururo.2013.11.045","volume":"66","author":"A Briganti","year":"2014","unstructured":"Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T (2014) Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. European Urology 66(3):479\u2013486. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2013.11.045","journal-title":"European Urology"},{"issue":"5","key":"408_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.eururo.2010.07.034","volume":"58","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G, Briganti A, Karakiewicz PI, Kattan MW, Montorsi F, Shariat SF, Vickers AJ (2010) Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. European Urology 58(5):687\u2013700. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2010.07.034","journal-title":"European Urology"},{"issue":"4","key":"408_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.eururo.2009.12.003","volume":"57","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G, Budaus L, Isbarn H, Sun M, Perrotte P, Haese A, Chun FK, Schlomm T, Steuber T, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI (2010) Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy. European Urology 57(4):562\u2013568. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2009.12.003","journal-title":"European Urology"},{"issue":"2","key":"408_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.juro.2008.10.033","volume":"181","author":"J Walz","year":"2009","unstructured":"Walz J, Chun FK, Klein EA, Reuther A, Saad F, Graefen M, Huland H, Karakiewicz PI (2009) Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. The Journal of Urology 181(2):601\u2013607; discussion 607-608. \n                    https:\/\/doi.org\/10.1016\/j.juro.2008.10.033","journal-title":"The Journal of Urology"},{"issue":"2","key":"408_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, Grading C (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. The American Journal of Surgical Pathology 40(2):244\u2013252. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000530","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"408_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.893","volume":"195","author":"L Bubendorf","year":"2001","unstructured":"Bubendorf L, Nocito A, Moch H, Sauter G (2001) Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. The Journal of Pathology 195(1):72\u201379. \n                    https:\/\/doi.org\/10.1002\/path.893","journal-title":"The Journal of Pathology"},{"issue":"3","key":"408_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/00000478-200203000-00004","volume":"26","author":"MA Rubin","year":"2002","unstructured":"Rubin MA, Dunn R, Strawderman M, Pienta KJ (2002) Tissue microarray sampling strategy for prostate Cancer biomarker analysis. The American Journal of Surgical Pathology 26(3):312\u2013319. \n                    https:\/\/doi.org\/10.1097\/00000478-200203000-00004","journal-title":"The American Journal of Surgical Pathology"},{"issue":"10","key":"408_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1464-410X.2008.07514.x","volume":"101","author":"JS Diallo","year":"2008","unstructured":"Diallo JS, Aldejmah A, Mouhim AF, Fahmy MA, Koumakpayi IH, Sircar K, Begin LR, Mes-Masson AM, Saad F (2008) Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis. BJU International 101(10):1302\u20131309. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07514.x","journal-title":"BJU International"},{"issue":"10","key":"408_CR19","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.ejca.2013.02.026","volume":"49","author":"PO Gannon","year":"2013","unstructured":"Gannon PO, Lessard L, Stevens LM, Forest V, Begin LR, Minner S, Tennstedt P, Schlomm T, Mes-Masson AM, Saad F (2013) Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer. European Journal of Cancer 49(10):2441\u20132448. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2013.02.026","journal-title":"European Journal of Cancer"},{"issue":"7","key":"408_CR20","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/sj.bjc.6605571","volume":"102","author":"IH Koumakpayi","year":"2010","unstructured":"Koumakpayi IH, Le Page C, Mes-Masson AM, Saad F (2010) Hierarchical clustering of immunohistochemical analysis of the activated ErbB\/PI3K\/Akt\/NF-kappaB signalling pathway and prognostic significance in prostate cancer. British Journal of Cancer 102(7):1163\u20131173. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6605571","journal-title":"British Journal of Cancer"},{"issue":"1","key":"408_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.eururo.2015.05.042","volume":"69","author":"AE Ross","year":"2016","unstructured":"Ross AE, Johnson MH, Yousefi K, Davicioni E, Netto GJ, Marchionni L, Fedor HL, Glavaris S, Choeurng V, Buerki C, Erho N, Lam LL, Humphreys EB, Faraj S, Bezerra SM, Han M, Partin AW, Trock BJ, Schaeffer EM (2016) Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate- and high-risk men. European Urology 69(1):157\u2013165. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.05.042","journal-title":"European Urology"},{"issue":"4","key":"408_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.eururo.2015.06.040","volume":"69","author":"RR Ruela-de-Sousa","year":"2016","unstructured":"Ruela-de-Sousa RR, Hoekstra E, Hoogland AM, Souza Queiroz KC, Peppelenbosch MP, Stubbs AP, Pelizzaro-Rocha K, van Leenders GJ, Jenster G, Aoyama H, Ferreira CV, Fuhler GM (2016) Low-molecular-weight protein tyrosine phosphatase predicts prostate Cancer outcome by increasing the metastatic potential. European Urology 69(4):710\u2013719. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.06.040","journal-title":"European Urology"},{"issue":"4","key":"408_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.eururo.2015.06.054","volume":"69","author":"A Belledant","year":"2016","unstructured":"Belledant A, Hovington H, Garcia L, Caron P, Brisson H, Villeneuve L, Simonyan D, Tetu B, Fradet Y, Lacombe L, Guillemette C, Levesque E (2016) The UGT2B28 sex-steroid inactivation pathway is a regulator of Steroidogenesis and modifies the risk of prostate Cancer progression. European Urology 69(4):601\u2013609. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.06.054","journal-title":"European Urology"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.eururo.2015.04.008","volume":"68","author":"PJ Bostrom","year":"2015","unstructured":"Bostrom PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, Cooperberg MR (2015) Genomic predictors of outcome in prostate Cancer. European Urology 68:1033\u20131044. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.04.008","journal-title":"European Urology"},{"issue":"1","key":"408_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.eururo.2014.11.030","volume":"68","author":"J Cullen","year":"2015","unstructured":"Cullen J, Rosner IL, Brand TC, Zhang N, Tsiatis AC, Moncur J, Ali A, Chen Y, Knezevic D, Maddala T, Lawrence HJ, Febbo PG, Srivastava S, Sesterhenn IA, McLeod DG (2015) A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with clinically low- and intermediate-risk prostate Cancer. European Urology 68(1):123\u2013131. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2014.11.030","journal-title":"European Urology"},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.eururo.2015.09.002","volume":"70","author":"S Eggener","year":"2015","unstructured":"Eggener S (2015) Prostate Cancer screening biomarkers: an emerging embarrassment of 'Riches'? European Urology 70:54\u201355. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.09.002","journal-title":"European Urology"},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.eururo.2015.04.012","volume":"68","author":"T Schlomm","year":"2015","unstructured":"Schlomm T, Weischenfeldt J, Korbel J, Sauter G (2015) The aging prostate is never \"normal\": implications from the genomic characterization of multifocal prostate cancers. European Urology 68:348\u2013350. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.04.012","journal-title":"European Urology"},{"issue":"4","key":"408_CR28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.eururo.2014.10.036","volume":"67","author":"EA Klein","year":"2015","unstructured":"Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E (2015) A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. European Urology 67(4):778\u2013786. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2014.10.036","journal-title":"European Urology"},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","volume":"70","author":"SA Tomlins","year":"2015","unstructured":"Tomlins SA, Day JR, Lonigro RJ, Hovelson DH, Siddiqui J, Kunju LP, Dunn RL, Meyer S, Hodge P, Groskopf J, Wei JT, Chinnaiyan AM (2015) Urine TMPRSS2:ERG plus PCA3 for individualized prostate Cancer risk assessment. European Urology 70:45\u201353. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.04.039","journal-title":"European Urology"},{"key":"408_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.eururo.2015.12.003","volume":"70","author":"R Mehra","year":"2015","unstructured":"Mehra R, Udager AM, Ahearn TU, Cao X, Feng FY, Loda M, Petimar JS, Kantoff P, Mucci LA, Chinnaiyan AM (2015) Overexpression of the long non-coding RNA SChLAP1 independently predicts lethal prostate Cancer. European Urology 70:549\u2013552. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.12.003","journal-title":"European Urology"},{"issue":"4","key":"408_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.eururo.2015.10.040","volume":"69","author":"MA Rubin","year":"2016","unstructured":"Rubin MA, Girelli G, Demichelis F (2016) Genomic correlates to the newly proposed grading prognostic groups for prostate Cancer. European Urology 69(4):557\u2013560. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.10.040","journal-title":"European Urology"},{"issue":"2","key":"408_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.eururo.2006.08.039","volume":"52","author":"FK Chun","year":"2007","unstructured":"Chun FK, Briganti A, Graefen M, Montorsi F, Porter C, Scattoni V, Gallina A, Walz J, Haese A, Steuber T, Erbersdobler A, Schlomm T, Ahyai SA, Currlin E, Valiquette L, Heinzer H, Rigatti P, Huland H, Karakiewicz PI (2007) Development and external validation of an extended 10-core biopsy nomogram. European Urology 52(2):436\u2013444. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2006.08.039","journal-title":"European Urology"},{"issue":"4","key":"408_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM (2015) Comparison of MR\/ultrasound fusion\u2013guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390\u2013397","journal-title":"JAMA"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-018-0408-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-018-0408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T05:34:50Z","timestamp":1567748090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-018-0408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s12253-018-0408-6","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"assertion":[{"value":"16 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"There are no conflicts of interest. The contents of this manuscript have not been copyrighted or published previously. The contents of this manuscript are not under consideration for publication elsewhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Informed written consent was obtained and ethical standards were adhered to.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standars"}}]}}